MedTrace Logo

Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green

NCT01335893 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-02-05

No results posted yet for this study

Summary

Our specific aim is to determine if Indocyanine Green (ICG) administered intraoperatively and imaged using our camera will aid in the identification of a suspected lung nodule.

Conditions

  • Lung Neoplasms

Interventions

DRUG

Indocyanine Green

Dose will be diluted in saline solution. This will be a single dose given before the surgery intravenously.

Sponsors & Collaborators

Principal Investigators

  • Sunil Singhal, MD · University of Pennsylvania

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-12-31
Completion
2014-12-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335893 on ClinicalTrials.gov